The Genomic Bottleneck: Silicon Scarcity, Commercial AI Prioritization, and the Life Sciences Squeeze
As commercial generative AI platforms consume the bulk of global semiconductor output, biomedical researchers face severe compute deficits that threaten to delay critical breakthroughs in oncology and genomic science.









